Table 3.
Variation and percent change in lumbar spine bone mineral density (g/cm2)
| P 1 | P 2 | P 3 | P 4 | P 5 | P 6 | P 7 | P 8 | |
|---|---|---|---|---|---|---|---|---|
| |
(M) |
(M) |
(F) |
(F) |
(F) |
(F) |
(F) |
(F) |
| LS BMD (g/cm2) at baseline |
0.707 |
0.611 |
0.790 |
0.623 |
0.784 |
0.455 |
0.423 |
0.598 |
| LS BMD (g/cm2) at 3 months |
0.761 |
0.668 |
0.884 |
0.650 |
0.846 |
0.493 |
0.495 |
0.672 |
| LS BMD (g/cm2) at 1 year |
0.749 |
0.660 |
0.879 |
0.650 |
0.844 |
0.488 |
0.491 |
0.667 |
| % change LS BMD at 3 months |
7.6 |
9.3 |
11.9 |
4.3 |
7.9 |
8.4 |
17.0 |
12.4 |
| % change LS BMD at 1 year |
5.9 |
8.0 |
11.3 |
4.3 |
7.7 |
7.3 |
16.1 |
11.5 |
| Effect on LS BMD | + | + | + | + | + | + | + | + |
P: Patient, (M): male, (F): female, LS: lumbar spine, BMD: bone mineral density, +: positive. The effect of cord blood mononuclear cells was considered as positive when the increase in bone mineral density was bigger than 1.5% at lumbar spine or when patients stopped loosing bone